Mirae Asset Global Etfs Holdings Ltd. Rallybio Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Rallybio Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 16,270 shares of RLYB stock, worth $16,107. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,270Holding current value
$16,107% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RLYB
# of Institutions
63Shares Held
32.1MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$4.15 Million0.02% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$3.6 Million1.68% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$3.59 Million2.28% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$3.27 Million5.39% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$3 Million0.1% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $31.8M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...